A team of researchers from the University of Houston and the University of Pennsylvania are working to bring a new biosensor for detecting the recurrence of prostate cancer to the doctor’s office.
“Such tests exist in clinical laboratories, but there remains a critical need for inexpensive, versatile and high-sensitivity diagnostic platforms which can bring the performance to the point of care or doctor’s office,” said Dmitri Litvinov, principal investigator and professor of electrical and computer engineering at the University of Houston. The work is funded by a $399,988 grant from the National Science Foundation.
The population that would immediately benefit from such a point-of-care test are prostate cancer patients who have undergone radical prostatectomy but have positive surgical margins, with cancer cells detected at the edge of the removed tissue. These patients are at high risk for recurrence, and long-term ultrasensitive prostate specific antigen (PSA) monitoring is required.
“An effective point of care PSA biosensor would simplify post-surgery testing, improve patient compliance and alleviate anxiety to help improve long-term patient outcomes,” said Litvinov.
The proposed biosensor platform will be based on an ultrahigh sensitivity magnetic nanoparticles detector and will look similar to a home pregnancy test with an electronic readout. As a bonus for healthcare providers and patients alike, it’s expected to cost under $3 per test.
The sensor, like the pregnancy test stick, is a lateral flow assay test, which detects the presence of condition-specific biomolecules (biomarkers) using appropriately designed biochemistry to trap biomarkers. Unlike the pregnancy test, which uses the color change in the test line as a readout, the new tool will use ultrasensitive sensing of magnetic nanoparticles trapped in a test line to detect trace amounts of prostate-specific antigen (PSA) in a patient’s blood.
“A pregnancy test is basically a ‘yes or no’ test. In our test, not only can we detect PSA at exceptionally small concentrations but we can also quantify how much PSA is present,” said Litvinov.
Because the tool will provide immediate information and be easily accessible, Litvinov believes it will provide early and affordable detection of disease recurrence. Timely identification of the appropriate treatment options can improve long-term patient outcomes.
“Our technology has potential to help improve survival rates with more accessible, affordable and easier testing,” said Litvinov.
Litvinov’s team includes co-principle investigator Richard Willson, UH professor of chemical and biomolecular engineering, and Ping Wang, associate professor of pathology and laboratory medicine at the Hospital of the University of Pennsylvania.
RT @SandyMcKayMD: @TXPeds proud of @UTHealth residents for making it a true daily double and making the right answer in Jacobi Jug. Bring h…
Listening to audiobooks while working out and trying to be as active as she can are just some of the ways dietitian Ann McMeans stays fit. See more of her healthy habits: https://t.co/0IgjhfKzMR #healthy #habits https://t.co/rZPxORppah
Some #cancer therapies can lead survivors to develop leukemia later on. Our @garciamanero shares how new research is helping predict which patients are most at risk: https://t.co/7s4XNeG7IR @cure_magazine #endcancer
RT @BCMHouston_News: When it floods, walking in water is sometimes unavoidable. Here is what to watch out for in the days following exposur…
RT @BCMCancerCenter: Learn about the latest updates in immunotherapy as well as hear from other cancer patients about their experience with…
@Majormac1 Sending good vibes your way, Robin.
Harris Health System@harrishealth
Happy Fall! https://t.co/wjF8teaVxm
Learn more about the rise of the anti-vaccination movement in @TexasChildrens second season of Outcomes. Listen here: https://t.co/4a9hcW4WyQ #OutcomesPodcast #TexasChildrens https://t.co/MxsKLH8Ory
RT @MoveItMonday: You don't have to leave your chair to #MoveItMonday! Try these three simple chair yoga exercises to stretch away stress,…
University of Houston@UHouston
RT @houstonalumni: Naming the mascot “Shasta” was an idea that came in 1947 when Alpha Phi Omega service fraternity bought UH’s first live…
#Clinicaltrials are at the core of our mission to #endcancer. Learn from our Dr. Patrick Hwu how they help us discover new treatments to benefit future and current patients: https://t.co/ENqWbPrvNt https://t.co/Jkuu9JlXbg
Today’s #VeteranOfTheDay is Army Veteran Charles J. Gestrich, who served as a railway mail clerk during the Korean War from 1951 to 1953: https://t.co/6mzBvGdZtR
@USMC Veteran Kionte lost his leg in an IED blast. During recovery, he experienced depression and sought support. Visit https://t.co/tBxE005jeW to hear more about Kionte’s journey back to physical and mental health.
Malawi’s national adoption of affordable neonatal CPAP technology developed at @Rice360atRiceU resulted in sustained improvements in the survival of babies with respiratory illness, according to a new study in the journal Pediatrics. https://t.co/mYtNlEf8uz
@USMC Veteran Kionte lost his leg in an IED blast. During his recovery, he experienced depression and sought support. Visit https://t.co/tBxE005jeW to hear more about Kionte’s journey back to physical and mental health.